Loxiglumide, a CCK‐A Antagonist, in Irritable Bowel Syndrome
- 1 March 1994
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 713 (1) , 449-450
- https://doi.org/10.1111/j.1749-6632.1994.tb44123.x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Therapeutic effects of loxiglumide, a cholecystokinin antagonist, on chronic constipation in elderly patients: a prospective, randomized, double‐blind, controlled trialNeurogastroenterology & Motility, 1993
- Perspectives of CCK antagonists in pancreatic research and clinical useInternational journal of pancreatology, 1991
- The Rational Use of CCK Antagonists in Irritable Bowel SyndromePublished by Springer Nature ,1991
- ROLE OF CHOLECYSTOKININ IN REGULATION OF GASTROINTESTINAL MOTOR FUNCTIONSThe Lancet, 1989
- EFFECT OF CHOLECYSTOKININ ON COLONIC MOTILITY AND SYMPTOMS IN PATIENTS WITH THE IRRITABLE-BOWEL SYNDROMEThe Lancet, 1973